Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Utilize diversification as a key strategy for wealth preservation. Safeguard your investments against market fluctuations.
23,542 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
When new Berkshire leadership takes the reins, investors wonder which names could ride along. Here’s why a flavor-foc...
A quick online search turned into a costly lesson when a creator clicked the first balance-check link for a Sephora g...
With American Express set to report on July 24, analysts say a durable franchise, disciplined capital returns, and a ...
Ethereum posted $478 million in net outflows over the past seven days, but top traders remain skeptical, highlighting...
As AI workloads surge, power reliability becomes a strategic bottleneck for data centers. This utility stock could of...
SpaceX sits at the edge of a dramatic valuation leap. This article explores a pivotal contract, the math behind a pos...
A UK-listed bitcoin treasury company uncovers a counterintuitive edge: buying back its own stock can yield about 24% ...
Stocks wavered as the Nasdaq led declines ahead of key tech earnings after the bell. Learn what moved markets, how to...
Bitwise CIO Matt Hougan contends this crypto winter much healthier than prior cycles, pointing to stronger on-chain a...
Bank-owned properties are climbing fast. This guide explains why the 25.7% increase matters, how it reshapes pricing ...
No stock goes straight up, and Walmart’s latest report is a perfect example. Strong e-commerce gains meet a cautious ...